Jeffrey C Allen

6PUBLICATIONS
55CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Neurology and neuromuscular diseasesOptical technologyNeurogenetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 27, 2025
Phase II study of axitinib in patients with NF2-related schwannomatosis and progressive vestibular schwannomas.

Mekka R Garcia, Mari Hagiwara, Anna Yaffe

|Oct 23, 2023
Impact of Rare and Multiple Concurrent Gene Fusions on Diagnostic DNA Methylation Classifier in Brain Tumors.

Kristyn Galbraith, Jonathan Serrano, Guomiao Shen

|Jul 07, 2021
Reliability of Handheld Dynamometry to Measure Focal Muscle Weakness in Neurofibromatosis Types 1 and 2.

Srivandana Akshintala, Nashwa Khalil, Kaleb Yohay

|Jan 28, 2021
NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.

Brian D Weiss, Pamela L Wolters, Scott R Plotkin

|Dec 18, 2020
Visual outcomes following everolimus targeted therapy for neurofibromatosis type 1-associated optic pathway gliomas in children.

Nicole J Ullrich, Sanjay P Prabhu, Roger J Packer

|Aug 26, 2020
Diffuse midline glioma with novel, potentially targetable, FGFR2-VPS35 fusion.

George Zanazzi, Benjamin L Liechty, Danielle Pendrick

Pageof 1

Frequent Collaborators

2 joint publications

Kaleb Yohay

2 joint publications

Scott R Plotkin

2 joint publications

Bruce R Korf

1 joint publications

Nicole J Ullrich